Gilead Sciences (NASDAQ:GILD – Free Report) had its target price lowered by Wells Fargo & Company from $90.00 to $84.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The firm currently has an equal weight rating on the biopharmaceutical company’s stock. Other equities research analysts have also issued research reports about […]
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its price objective lowered by equities researchers at Wells Fargo & Company from $90.00 to $84.00 in a research report issued on Wednesday, Benzinga reports. The firm presently has an “equal weight” rating on the biopharmaceutical company’s stock. Wells Fargo & Company‘s price target indicates a potential […]
Gilead Sciences (NASDAQ:GILD – Get Free Report) had its target price decreased by equities researchers at Royal Bank of Canada from $78.00 to $76.00 in a report released on Wednesday, Benzinga reports. The firm currently has a “sector perform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price objective would suggest a potential […]
Gilead Sciences (NASDAQ:GILD) Price Target Cut to $78 00 theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Gilead Sciences, Inc (NASDAQ:GILD) Receives $87 20 Average Target Price from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.